Metastatic HER2-Negative Breast Cancer – Chemo- and Targeted Therapy Guidelines Pocket Guide - Guideline Central

Metastatic HER2-Negative Breast Cancer – Chemo- and Targeted Therapy

American Society of Clinical OncologyPublished: January 10, 2023
  • Pages:8
  • Format:MultiFold
  • Dimensions:4.25" x 7.25"
$9.95
A PDF version of this Pocket Guide is also available!
$9.95
A digital version of this pocket guide is available for FREE at this link
  • Introduction 
  • New Recommendation from 2023 Guideline Rapid Recommendation Update
  • New Recommendation from 2022 Guideline Rapid Recommendation Update
  • Table 
    • Targeted Therapies for Metastatic (or locally advanced) Breast Cancer
  • Figures 
    • Management of Metastatic HR-positive Breast Cancer
    • Management of Metastatic Triple Negative Breast Cancer
Also Found In

ASCO Guidelines Bundle

$935.95
Related Products
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.